That is notable as these titers were connected with 95% protection from COVID-19 in phase 3 trials (44, 46, 48, 49)
That is notable as these titers were connected with 95% protection from COVID-19 in phase 3 trials (44, 46, 48, 49). countries (1C3). Infections is mediated with the viral spike proteins (S) which is certainly made up of an S1 area which has a N-terminal area (NTD), a C-terminal area (CTD), and a receptor binding…
Read more